Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of The Effect of Cell-Free Cord Blood Derived Microvesicles On β-cell Mass in Type 1 Diabetes Mellitus (T1DM) Patients

NCT02138331 is registered in ClinicalTrials.gov with General Committee of Teaching Hospitals and Institutes, Egypt as lead sponsor.

NCT NCT02138331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02138331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of The Effect of Cell-Free Cord Blood Derived Microvesicles On β-cell Mass in Type 1 Diabetes Mellitus (T1DM) Patients
Lead sponsor
General Committee of Teaching Hospitals and Institutes, Egypt
Phase
Phase 2/3
Overall status
Unknown status
Start date
April 30, 2014
Completion date
September 30, 2014
Enrollment
20 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 1